A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study

Background Minimal change disease (MCD) is a common pathological type of nephrotic syndrome. Relapses of MCD present a significant challenge for patients. This study aims to develop a predictive model for evaluating the probability of relapse in patients with MCD.Methods This study enrolled 152 pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Lefeng Wang, Qinfan Yao, Ying Zhang, Xuan Zhang, Mengjie Hu, Jianpeng Chen, Xiayu Li, Jianghua Chen, Heng Li
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2423007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689790129111040
author Lefeng Wang
Qinfan Yao
Ying Zhang
Xuan Zhang
Mengjie Hu
Jianpeng Chen
Xiayu Li
Jianghua Chen
Heng Li
author_facet Lefeng Wang
Qinfan Yao
Ying Zhang
Xuan Zhang
Mengjie Hu
Jianpeng Chen
Xiayu Li
Jianghua Chen
Heng Li
author_sort Lefeng Wang
collection DOAJ
description Background Minimal change disease (MCD) is a common pathological type of nephrotic syndrome. Relapses of MCD present a significant challenge for patients. This study aims to develop a predictive model for evaluating the probability of relapse in patients with MCD.Methods This study enrolled 152 patients with biopsy-confirmed MCD, all of whom received exclusive glucocorticoid treatment at the First Affiliated Hospital of Zhejiang University in Hangzhou, China, between October 2012 and April 2021. The Cox regression analysis was utilized to identify the risk factors associated with the relapse in MCD, and a nomogram was constructed to predict the probability of relapse.Results The results demonstrated that serum immunoglobulin E (IgE) levels > 936 IU/mL, age ≤ 30 years old, estimated glomerular filtration rate (eGFR) < 90 mL/(min × 1.73 m2), serum total cholesterol (TCh) levels > 12.3 mmol/L, and time to remission were independent risk factors associated with relapses in patients with MCD. A nomogram was established and achieved a concordance index of 0.726 (95% CI = 0.659–0.793). The receiver operating characteristic curves demonstrated areas under the curve of 0.771, 0.853, and 0.811 for the prediction of relapse at 1-, 2-, and 3-year intervals after achieving remission in MCD patients respectively. These findings along with the calibration curves indicated the good discrimination and calibration performance of the nomogram in this cohort.Conclusion: The established nomogram provides a valuable tool for the identification of patients with MCD who are at risk of relapse, which may facilitate prompt treatment for these patients.
format Article
id doaj-art-0cc54319892b4f8fa44cb7c52ecb8d2a
institution DOAJ
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-0cc54319892b4f8fa44cb7c52ecb8d2a2025-08-20T03:21:31ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146210.1080/0886022X.2024.2423007A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort studyLefeng Wang0Qinfan Yao1Ying Zhang2Xuan Zhang3Mengjie Hu4Jianpeng Chen5Xiayu Li6Jianghua Chen7Heng Li8Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaKidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaKidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Cardiology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of General Practice, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaKidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaKidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaBackground Minimal change disease (MCD) is a common pathological type of nephrotic syndrome. Relapses of MCD present a significant challenge for patients. This study aims to develop a predictive model for evaluating the probability of relapse in patients with MCD.Methods This study enrolled 152 patients with biopsy-confirmed MCD, all of whom received exclusive glucocorticoid treatment at the First Affiliated Hospital of Zhejiang University in Hangzhou, China, between October 2012 and April 2021. The Cox regression analysis was utilized to identify the risk factors associated with the relapse in MCD, and a nomogram was constructed to predict the probability of relapse.Results The results demonstrated that serum immunoglobulin E (IgE) levels > 936 IU/mL, age ≤ 30 years old, estimated glomerular filtration rate (eGFR) < 90 mL/(min × 1.73 m2), serum total cholesterol (TCh) levels > 12.3 mmol/L, and time to remission were independent risk factors associated with relapses in patients with MCD. A nomogram was established and achieved a concordance index of 0.726 (95% CI = 0.659–0.793). The receiver operating characteristic curves demonstrated areas under the curve of 0.771, 0.853, and 0.811 for the prediction of relapse at 1-, 2-, and 3-year intervals after achieving remission in MCD patients respectively. These findings along with the calibration curves indicated the good discrimination and calibration performance of the nomogram in this cohort.Conclusion: The established nomogram provides a valuable tool for the identification of patients with MCD who are at risk of relapse, which may facilitate prompt treatment for these patients.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2423007Minimal change diseasenomogramrelapserisk factorserum IgE levels
spellingShingle Lefeng Wang
Qinfan Yao
Ying Zhang
Xuan Zhang
Mengjie Hu
Jianpeng Chen
Xiayu Li
Jianghua Chen
Heng Li
A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
Renal Failure
Minimal change disease
nomogram
relapse
risk factor
serum IgE levels
title A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
title_full A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
title_fullStr A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
title_full_unstemmed A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
title_short A nomogram to predict the risk of relapse in patients with minimal change disease: a retrospective cohort study
title_sort nomogram to predict the risk of relapse in patients with minimal change disease a retrospective cohort study
topic Minimal change disease
nomogram
relapse
risk factor
serum IgE levels
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2423007
work_keys_str_mv AT lefengwang anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT qinfanyao anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT yingzhang anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT xuanzhang anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT mengjiehu anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT jianpengchen anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT xiayuli anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT jianghuachen anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT hengli anomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT lefengwang nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT qinfanyao nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT yingzhang nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT xuanzhang nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT mengjiehu nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT jianpengchen nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT xiayuli nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT jianghuachen nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy
AT hengli nomogramtopredicttheriskofrelapseinpatientswithminimalchangediseasearetrospectivecohortstudy